
Compugen Ltd. CGEN
$ 1.8
4.97%
Annual report 2024
added 02-07-2026
Compugen Ltd. ROA Ratio 2011-2026 | CGEN
Annual ROA Ratio Compugen Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12.38 | -15.46 | -35.78 | -25.88 | -21.47 | -50.85 | -42.5 | -95.66 | -44.29 | -20.3 | -9.65 | -24.83 | -47.15 | -41.26 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -9.65 | -95.66 | -34.82 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | ||
|
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M | ||
|
ANI Pharmaceuticals
ANIP
|
-1.44 | $ 80.97 | 0.78 % | $ 1.56 B | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-40.29 | - | -15.15 % | $ 60.3 M | ||
|
Adverum Biotechnologies
ADVM
|
-72.8 | - | - | $ 86.2 M | ||
|
Amarin Corporation plc
AMRN
|
-7.11 | $ 14.8 | 0.34 % | $ 6.03 B | ||
|
Acasti Pharma
ACST
|
-13.29 | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
7.43 | - | - | $ 866 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-27.57 | - | - | $ 26.5 M | ||
|
Aptorum Group Limited
APM
|
-26.46 | $ 0.87 | 6.7 % | $ 4.74 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
-37.44 | $ 2.63 | -1.5 % | $ 148 M | ||
|
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M | ||
|
AlloVir
ALVR
|
-49.57 | - | 4.14 % | $ 49.1 M | ||
|
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | ||
|
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.55 | -0.56 % | $ 8.54 B | ||
|
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | ||
|
ARCA biopharma
ABIO
|
-21.14 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | ||
|
Akero Therapeutics
AKRO
|
-30.52 | - | - | $ 3.67 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-34.19 | - | - | $ 1.01 B | ||
|
Aptose Biosciences
APTO
|
-251.11 | - | -45.71 % | $ 1.2 M | ||
|
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-35.36 | $ 221.53 | -0.23 % | $ 5 B | ||
|
Allena Pharmaceuticals
ALNA
|
-140.01 | - | 3.16 % | $ 1.9 M | ||
|
Aptinyx
APTX
|
-97.25 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | ||
|
BioNTech SE
BNTX
|
65.02 | $ 112.43 | 1.89 % | $ 27.2 B | ||
|
Cabaletta Bio
CABA
|
-26.68 | $ 2.59 | 5.94 % | $ 3.03 M | ||
|
Arena Pharmaceuticals
ARNA
|
-78.56 | - | -6.81 % | $ 3.04 B | ||
|
Aridis Pharmaceuticals
ARDS
|
-206.68 | - | 17.91 % | $ 11.1 M | ||
|
Burford Capital Limited
BUR
|
5.51 | $ 9.29 | 3.45 % | $ 1.45 B | ||
|
Aeterna Zentaris
AEZS
|
-10.45 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-123.72 | - | -10.17 % | $ 12.2 K | ||
|
Athira Pharma
ATHA
|
-164.92 | - | - | $ 269 M | ||
|
Athersys
ATHX
|
-144.48 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-31.09 | - | 0.23 % | $ 488 M | ||
|
Avenue Therapeutics
ATXI
|
-437.72 | - | -52.27 % | $ 4.45 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-86.4 | $ 4.55 | 6.29 % | $ 9.9 B | ||
|
Autolus Therapeutics plc
AUTL
|
-28.19 | $ 1.46 | -0.1 % | $ 373 M | ||
|
Amneal Pharmaceuticals
AMRX
|
-2.11 | $ 14.52 | - | $ 4.49 B | ||
|
Codexis
CDXS
|
-43.81 | $ 1.29 | 0.01 % | $ 94.7 M | ||
|
AIkido Pharma
AIKI
|
-31.2 | - | 1.93 % | $ 17.4 M | ||
|
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | ||
|
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | ||
|
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M |